No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Yvon Englert, Dominique Bron et al.|Journal of Clinical Oncology|2016Cited by 241
Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized TrialIsabelle Demeestere, Yvon Englert, Pauline Brice et al.|Journal of Clinical Oncology|2012Cited by 121
Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkersOranite Goldrat, Isabelle Demeestere, Géraldine Van Den Steen et al.|Reproductive Biology and Endocrinology|2019Cited by 29
Reply to M. Lambertini et alIsabelle Demeestere, Yvon Englert, Pauline Brice et al.|Journal of Clinical Oncology|2017Cited by 3
Triptorelin to prevent chemotherapy-induced ovarian failure in lymphoma patients: a prospective randomized study.Isabelle Demeestere, Yvon Englert, Pauline Brice et al.|Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)|2013Cited by 3